Hormone receptor status of breast cancer in India: A study of 798 tumours

88Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

The objectives of this study were to document the oestrogen and progesterone receptor (ER and PR) status of breast cancer in the Indian population (as done by immunohistochemistry on paraffin blocks), and correlate the steroid receptor status of breast cancer with all relevant patient and tumour characteristics. Our current data have been compared with previously published data from other centres. In contrast to the higher rates reported in the Western literature, only 32.6% of our tumours were ER positive and 46.1% were PR positive. Tumours were separated into four categories: ER+PR+ (25%), ER+PR- (7.4%), ER-PR+ (21.1%) and ER-PR- (46.5%). ER and PR immunoreactivity increased with advancing age, and correlated with the presence of elastosis. Infiltrating lobular carcinoma, mucinous carcinoma, and mixed tumours were more frequently ER and PR positive. High-grade infiltrating duct carcinomas, pure comedo ductal carcinoma in situ, and medullary carcinoma were predominantly ER and PR negative. The presence of necrosis and lymphovascular invasion showed an inverse relationship with ER and PR reactivity. (C) 2000 Harcourt Publishers Ltd.

Cite

CITATION STYLE

APA

Desai, S. B., Moonim, M. T., Gill, A. K., Punia, R. S., Naresh, K. N., & Chinoy, R. F. (2000). Hormone receptor status of breast cancer in India: A study of 798 tumours. Breast, 9(5), 267–270. https://doi.org/10.1054/brst.2000.0134

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free